Snow Capital Management’s Medifast MED Stock Holding History

Snow Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,866	Closed	-$1.37M	–	144
2020 Q2	$1.37M	Sell	9,866 -14,139	-59%	-$1.3M	0.28%	85
2020 Q1	$1.5M	Sell	24,005 -9,211	-28%	-$839K	0.34%	72
2019 Q4	$3.64M	Buy	33,216 +26,966	+431%	+$2.61M	0.5%	53
2019 Q3	$648K	Buy	+6,250	New	+$672K	0.05%	109
2014 Q4	–	Sell	-39,500	Closed	-$1.3M	–	145
2014 Q3	$1.3M	Sell	39,500 -14,400	-27%	-$442K	0.05%	101
2014 Q2	$1.64M	Sell	53,900 -39,980	-43%	-$1.25M	0.06%	85
2014 Q1	$2.73M	Buy	93,880 +15,555	+20%	+$417K	0.11%	71
2013 Q4	$2.05M	Buy	78,325 +21,220	+37%	+$544K	0.08%	71
2013 Q3	$1.54M	Buy	57,105 +12,615	+28%	+$337K	0.07%	77
2013 Q2	$1.15M	Buy	+44,490	New	+$1.17M	0.05%	82

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Snow Capital Management's MED Position: Q3 2020 in Review

Snow Capital Management sold out of Medifast (MED) in Q3 2020, closing a stake of 9,866 shares — an estimated $1.37M sold.

Snow Capital Management first reported a position in MED in Q2 2013 and held it in 10 quarters. The position peaked at $3.64M in Q4 2019. 240 funds tracked by Wall St. Rank hold MED as of Q3 2020.

Snow Capital Management reported no remaining Medifast position as of Q3 2020 after selling out during the quarter.
Snow Capital Management sold 9,866 Medifast shares in Q3 2020, an estimated $1.37M.
Snow Capital Management first reported a position in Medifast in Q2 2013 and held it in 10 quarters.
Snow Capital Management's Medifast position peaked at $3.64M in Q4 2019.
240 funds tracked by Wall St. Rank held Medifast as of Q3 2020.

Based on Snow Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.